Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$536,892
-$37,786 QoQ
Shares Held
2,114
-10.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#3,621
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PAX Financial Group, LLC holds $3,929,562 across 7 Drug Manufacturers - General names. JNJ ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,103 | $1,322,971 | |
| 2 | NVO |
Novo Nordisk A S
|
13,437 | $644,169 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
2,114 | $536,892 | |
| 4 | ABBV |
AbbVie Inc.
|
2,019 | $508,061 | |
| 5 | AZN |
Astrazeneca PLC
|
2,504 | $474,808 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,794 | $226,653 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,681 | $216,008 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,892 | 2,114 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $574,678 | 2,351 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $509,097 | 2,460 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $461,881 | 2,491 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $409,217 | 2,679 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $731,354 | 4,410 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $649,633 | 4,492 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $711,281 | 4,389 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $617,818 | 4,227 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $611,878 | 3,868 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $604,389 | 3,856 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $577,832 | 3,710 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $626,824 | 3,787 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $583,420 | 3,764 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $681,515 | 3,858 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $720,744 | 4,412 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $796,487 | 4,487 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,022,971 | 5,772 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $995,285 | 5,818 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $901,816 | 5,584 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $916,613 | 5,564 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $852,976 | 5,190 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $691,055 | 4,391 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $638,992 | 4,292 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $543,113 | 3,862 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $459,741 | 3,506 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||